Introduction
Drug-eluting stent (DES) has contributed to reduce stent restenosis of the chronic phase. However, stent thrombosis remains a critical issue in the percutaneous coronary intervention (PCI). Peri-strut contrast staining (PSS) is one of the late-acquired phenomena after DES implantation, and has the potential cause of stent thrombosis. 1, 2) Although drug-coated balloon (DCB) has been widely used as a useful device for in-stent restenosis, the adverse event has been still unknown especially at the chronic phase after DCB angioplasty. We describe Peri-strut contrast staining (PSS) is rarely observed after drug-eluting stent implantation and has the potential cause of stent thrombosis. A 68-year-old man with ST-elevation myocardial infarction (STEMI) underwent primary percutaneous coronary intervention (PCI) for a totally occluded left anterior descending artery. The lesion was successfully dilated with an everolimus-eluting stent. Ten months later, follow-up angiography revealed in-stent occlusion and revascularization was performed by drug-coated balloon (DCB) angioplasty. Another 12 months after the second PCI, PSS was found at the previous occlusion site. Optical frequency domain imaging (OFDI) was performed for the PSS lesion and showed malapposed stent struts with a protruded mass with irregular surface behind the stent struts, and coronary angioscopy also revealed completely exposed stent struts with an abutting yellow plaque. From these multimodality imaging findings, the possibility was assumed the pathogeneses of PSS, which is thrombus dissolution after stent under dilation for culprit lesion, and the progression of vessel ectasia under the condition of continuing inflammation after drug-eluting stent (DES) implantation and DCB angioplasty. Medtronic, Santa Rosa, CA, USA) were implanted (Fig. 2B ).
Case Report
Final intravascular ultrasound found no stent under-expansion or stent malapposition. DAPT was continued after a second PCI.
He complained no chest symptom and planned follow-up CAG was performed 12 months after the second PCI for LAD. The angiogram showed no restenosis, but showed contrast staining outside the stent contour at the lesion after EES implantation ( Fig. 3A; arrows) . For more detailed evaluation of the lesion characteristics, optical frequency domain imaging (OFDI;
Terumo Corporation, Tokyo, Japan) and coronary angioscopy (Inter-Tec, Medicals. Corp., Osaka, Japan) were performed.
OFDI demonstrated malapposed struts with maximum lumen diameter 3.6 mm and with stent diameter 2.5 mm (Fig. 3b ). This OFDI finding supported the diagnosis of angiographic ectasia as PSS. Another OFDI finding demonstrated irregular surface behind the malapposed stent struts (Fig. 3c) . Each corresponding angioscopic image revealed that stent struts were completely exposed with evidence of blood flow behind the strut (Fig. 3b′ and 3c′). At the proximal just to the malapposed lesion, OFDI showed stent struts were slightly covered by neointima ( Fig. 3a) .
At the corresponding lesion, coronary angioscopy demonstrated that stent struts were visible with dull light reflection, and detected yellow plaque under the struts (Fig. 3a′ ).
Discussion
This is the case report late-acquired PSS after angioplasty evaluated by OFDI and angioscopy. PSS is angiographically defined as contrast staining outside the stent contour extending to >20% of the stent diameter, and was recognized as stent malapposition. Several studies demonstrated that PSS is associated with endothelial delayed healing and has a potential risk of stent thrombosis. 1, 2) The major cause of PSS is regarded as the chronic inflammation, thrombus, chronic total occlusion, and DES implantation. It is also pointed out that second generation DES like EES could be the cause of PSS. 3) In this case, PSS developed after EES implantation and DCB angioplasty. OFDI revealed a protruded mass consisted of contour irregularity with strong attenuation behind the malapposed stent struts. We also underwent coronary angioscopic examination to visualize the vascular lumen of PSS. Coronary angioscopy showed poor neointimal coverage with a yellow plaque under stent struts. Peri-strut contrast staining 12 months after DCB angioplasty (A). OFDI showed that stent struts were completely exposed (b). There was a protruded mass with irregular surface behind the stent struts (c). Corresponding angioscopic findings revealed completely exposed stent struts (b′, c′, participate blood flow findings was observed due to insufficient blood exclusion). At the proximal just to the malapposed struts lesion, OFDI showed stent struts were slightly covered by neointima (a). Angioscopy showed visible stent strut with dull light reflection and yellow plaque under the struts (a′). EES: everolimus-eluting stent, DCB: drug-coated balloon, OFDI: optical frequency domain imaging 
Conclusion
There is a possibility that DCB angioplasty contributes to PSS development after DES implantation for STEMI patient.
OFDI and angioscopic findings are useful for the evaluation of the PSS pathogenesis.
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